Media Release

Initial funding opens doors for national vaccine strategy

New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
Media Release

Call for doctors to attend medicinal cannabis summit

“New Zealand healthcare professionals who say they don’t know enough about medicinal cannabis now have the best opportunity to change that,” says Dr Zahra Champion, Executive Director of BioTechNZ and MedCan Summit 2020 organiser.
Media Release

Biotech in NZ on cusp of saving sick pets

NZ biotech companies and organisations are exploring cutting-edge research to help treat people, but that will soon be swiftly replicated for dogs, cats and other pets.